Literature DB >> 16303225

Are nonpharmacological induced rewards related to anhedonia? A study among skydivers.

Ingmar H A Franken1, Corien Zijlstra, Peter Muris.   

Abstract

It is well-known that persons with a drug addiction experience feelings of anhedonia during "normal" daily activities. It has been proposed that these symptoms of anhedonia are the result of direct pharmacological influences of drugs on the dopamine system. To test the assumption that nonpharmacological processes are also involved in anhedonia, we studied anhedonic symptoms in skydivers who regularly expose themselves to thrillful extreme sport activity and then experience intense hedonic feelings. A group of skydivers completed anhedonia scales and their scores were compared to a control group (a group of rowers). The main finding of the present study was that subjects who engage in the high-risk activity of skydiving, experienced more anhedonic symptoms than subjects who do not engage in such an extreme sport, but rather prefer a low-risk activity like rowing. This finding supports the notion that skydiving has similarities with addictive behaviors and that frequent exposure to "natural high" experiences is related to anhedonia. This suggests that the negative emotional state as observed in drug users may not be exclusively the results of exogenous psychopharmacological effects, but might also result from psychological mechanisms that are partly responsible for these anhedonic feelings.

Entities:  

Mesh:

Year:  2005        PMID: 16303225     DOI: 10.1016/j.pnpbp.2005.10.011

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  12 in total

1.  Gender differences in the relationship between affect and adolescent smoking uptake.

Authors:  Janet Audrain-McGovern; Daniel Rodriguez; Adam M Leventhal
Journal:  Addiction       Date:  2015-01-05       Impact factor: 6.526

Review 2.  Anxiety, depression, and cigarette smoking: a transdiagnostic vulnerability framework to understanding emotion-smoking comorbidity.

Authors:  Adam M Leventhal; Michael J Zvolensky
Journal:  Psychol Bull       Date:  2014-11-03       Impact factor: 17.737

Review 3.  Substance misuse prevention: addressing anhedonia.

Authors:  Steve Sussman; Adam Leventhal
Journal:  New Dir Youth Dev       Date:  2014

4.  Regulating task-monitoring systems in response to variable reward contingencies and outcomes in cocaine addicts.

Authors:  Kristen P Morie; Pierfilippo De Sanctis; Hugh Garavan; John J Foxe
Journal:  Psychopharmacology (Berl)       Date:  2016-02-10       Impact factor: 4.530

5.  Anhedonia as a phenotypic marker of familial transmission of polysubstance use trajectories across midadolescence.

Authors:  Junhan Cho; Mattew D Stone; Adam M Leventhal
Journal:  Psychol Addict Behav       Date:  2018-11-19

6.  Anhedonia and substance dependence: clinical correlates and treatment options.

Authors:  Daniele Stavros Hatzigiakoumis; Giovanni Martinotti; Massimo Di Giannantonio; Luigi Janiri
Journal:  Front Psychiatry       Date:  2011-03-17       Impact factor: 4.157

7.  Experience, cortisol reactivity, and the coordination of emotional responses to skydiving.

Authors:  Vanessa J Meyer; Yoojin Lee; Christian Böttger; Uwe Leonbacher; Amber L Allison; Elizabeth A Shirtcliff
Journal:  Front Hum Neurosci       Date:  2015-03-25       Impact factor: 3.169

8.  Development and Initial Validation of a Rock Climbing Craving Questionnaire (RCCQ).

Authors:  Gareth Roderique-Davies; Robert M Heirene; Stephen Mellalieu; David A Shearer
Journal:  Front Psychol       Date:  2018-02-22

Review 9.  Neurobiological mechanisms of anhedonia.

Authors:  Philip Gorwood
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

10.  Addiction in Extreme Sports: An Exploration of Withdrawal States in Rock Climbers.

Authors:  Robert M Heirene; David Shearer; Gareth Roderique-Davies; Stephen D Mellalieu
Journal:  J Behav Addict       Date:  2016-06-27       Impact factor: 6.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.